AM-133

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAM-133
Drug Alias Namerecombinant VEGF-B (Zenyth/LICR)AM-133
ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionVascular endothelial growth factor receptor stimulants
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwedenAustralia and New Zealand
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCSL Innovation PTY Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCSL Innovation PTY LtdEdwards Lifesciences CorpLudwig Institute For Cancer Research +[4] 
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A